Building on Tacti-002 AIPAC needs an eftilagimod c/w pd1 arm in AIPAC trial.
This is where we can see substantial improvement c/w pd1 chemo trials.
Media, page-120
-
- There are more pages in this discussion • 263 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.3¢ |
Change
0.013(3.68%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.5¢ | 34.0¢ | $548.3K | 1.578M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 208473 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 391133 | 41 |
View Market Depth
| Last trade - 13.02pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |